Cargando…
No difference in cerebral perfusion between the wild-type and the 5XFAD mouse model of Alzheimer’s disease
Neuroimaging with [2,2-dimethyl-3-[(2R,3E)-3-oxidoiminobutan-2-yl]azanidylpropyl]-[(2R,3E)-3-hydroxyiminobutan-2-yl]azanide;oxo((99)Tc)technetium-99(3+) ([(99m)Tc]HMPAO) single photon emission computed tomography (SPECT) is used in Alzheimer’s disease (AD) to evaluate regional cerebral blood flow (r...
Autores principales: | DeBay, Drew R., Phi, Tân-Trào, Bowen, Chris V., Burrell, Steven C., Darvesh, Sultan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780330/ https://www.ncbi.nlm.nih.gov/pubmed/36550188 http://dx.doi.org/10.1038/s41598-022-26713-x |
Ejemplares similares
-
Early Detection of Cerebral Glucose Uptake Changes in the 5XFAD Mouse
por: I.R, Macdonald, et al.
Publicado: (2014) -
Targeting butyrylcholinesterase for preclinical single photon emission computed tomography (SPECT) imaging of Alzheimer's disease
por: DeBay, Drew R., et al.
Publicado: (2017) -
Quantification of Butyrylcholinesterase Activity as a Sensitive and Specific Biomarker of Alzheimer’s Disease
por: Macdonald, Ian R., et al.
Publicado: (2017) -
ER stress is not elevated in the 5XFAD mouse model of Alzheimer's disease
por: Sadleir, Katherine R., et al.
Publicado: (2018) -
Phloroglucinol Attenuates the Cognitive Deficits of the 5XFAD Mouse Model of Alzheimer’s Disease
por: Yang, Eun-Jeong, et al.
Publicado: (2015)